Incidence, Risk Factors, and Modified Risk Assessment Model of Venous Thromboembolism in Non‐Hodgkin Lymphoma Patients
ABSTRACT Background Venous thromboembolic events (VTEs) are the second‐leading cause of death in cancer patients, with an incidence of 5%–17% in lymphoma patients, particularly higher in those with non‐Hodgkin lymphoma (NHL). Existing risk assessment models (RAMs) like the Khorana and ThroLy scores...
Saved in:
Main Authors: | Wen Li, Rui Liu, Ying Shen, GongZhizi Gao, Rui Yang, Yiwen Wang, Ruoyu Yang, Zujie Lin, Ruijun Dong, Wanhong Zhao, Aili He, Ju Bai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-12-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70510 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of recurrence and bleeding in patients with cancer‐associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
by: Mette Søgaard, et al.
Published: (2019-03-01) -
Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
by: Jonatan Ahrén, et al.
Published: (2025-03-01) -
Biological Aging and Venous Thromboembolism: A Review of Telomeres and Beyond
by: Rafaela Vostatek, et al.
Published: (2024-12-01) -
Risk factors for venous thromboembolism after hip arthroscopy: a systematic review and meta-analysis
by: Haoxuan Li, et al.
Published: (2025-02-01) -
Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?
by: Yachar Dawudi, et al.
Published: (2025-01-01)